×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CLLS – cellectis s.a. - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CLLS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/19
06:18 am
clls
Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells
Medium
Report
Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells
11/7
11:08 pm
clls
Cellectis GAAP EPS of $0.01 beats by $0.24, revenue of $37.16M [Seeking Alpha]
Medium
Report
Cellectis GAAP EPS of $0.01 beats by $0.24, revenue of $37.16M [Seeking Alpha]
11/7
04:49 pm
clls
Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
11/7
04:30 pm
clls
Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update
Medium
Report
Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update
11/3
09:15 am
clls
Cellectis to Present a Development Update for eti-cel at ASH 2025
Medium
Report
Cellectis to Present a Development Update for eti-cel at ASH 2025
10/31
04:30 pm
clls
Cellectis to Report Third Quarter Financial Results on November 7, 2025
Medium
Report
Cellectis to Report Third Quarter Financial Results on November 7, 2025
10/20
07:21 am
clls
Cellectis (NASDAQ:CLLS) had its "positive" rating reaffirmed by analysts at Wells Fargo & Company.
Low
Report
Cellectis (NASDAQ:CLLS) had its "positive" rating reaffirmed by analysts at Wells Fargo & Company.
10/17
06:03 am
clls
Cellectis (NASDAQ:CLLS) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Medium
Report
Cellectis (NASDAQ:CLLS) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Date
Time
Symbol
Company Name
Action
%Chg
3/13/2025
06:07 pm
CLLS
cellectis s.a. - american depositary shares
MISS
Report
-3.9%
cellectis s.a. - american depositary shares
3/13/2025
06:07 pm
CLLS
cellectis s.a. - american depositary shares
MISS
Report
-3.9%
cellectis s.a. - american depositary shares
3/13/2025
06:07 pm
CLLS
cellectis s.a. - american depositary shares
MISS
Report
-3.9%
cellectis s.a. - american depositary shares
3/13/2025
06:07 pm
CLLS
cellectis s.a. - american depositary shares
MISS
Report
-3.9%
cellectis s.a. - american depositary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/19
06:35 am
clls
Form 6-K Cellectis S.A. For: Nov 19
Low
Report
Form 6-K Cellectis S.A. For: Nov 19
11/7
04:30 pm
clls
Form 6-K Cellectis S.A. For: Nov 07
Medium
Report
Form 6-K Cellectis S.A. For: Nov 07
11/3
09:20 am
clls
Form 6-K Cellectis S.A. For: Nov 03
Medium
Report
Form 6-K Cellectis S.A. For: Nov 03
10/31
04:35 pm
clls
Form 6-K Cellectis S.A. For: Oct 29
Medium
Report
Form 6-K Cellectis S.A. For: Oct 29
10/17
07:00 am
clls
Form 6-K Cellectis S.A. For: Oct 16
Medium
Report
Form 6-K Cellectis S.A. For: Oct 16
10/16
07:05 am
clls
Form 6-K Cellectis S.A. For: Oct 16
High
Report
Form 6-K Cellectis S.A. For: Oct 16
10/14
04:31 pm
clls
Form 6-K/A Cellectis S.A. For: Jun 30
Low
Report
Form 6-K/A Cellectis S.A. For: Jun 30
10/7
06:03 am
clls
Form 6-K Cellectis S.A. For: Oct 07
Medium
Report
Form 6-K Cellectis S.A. For: Oct 07
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/17
3 “Strong Buy” Healthcare Stocks That Can Double in 2020 [Yahoo! Finance News]
14.3%
4/13 Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer 13.0%
2/18 Cellectis and Servier Expand Collaboration on UCART19 Products 9.2%
10/29 Form 6-K Cellectis S.A. For: Oct 29 7.5%
8/7 Cellectis: Monthly Information on Share Capital and Company Voting Rights 6.6%
1/9 Cellectis: Monthly Information on Share Capital and Company Voting Rights 5.7%
8/17 Cellectis SA (NASDAQ: CLLS) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 5.0%
10/31 Cellectis to Hold Third Quarter and First Nine Months 2019 Earnings Call on Thursday, November 7, 2019 at 8:00 AM EST 4.0%
11/8 Cellectis: Monthly information on share capital and company voting rights 3.8%
2/12 Cellectis SA (NASDAQ: CLLS) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.5%
4/13 Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer 13.0%
2/18 Cellectis and Servier Expand Collaboration on UCART19 Products 9.2%
10/29 Form 6-K Cellectis S.A. For: Oct 29 7.5%
8/7 Cellectis: Monthly Information on Share Capital and Company Voting Rights 6.6%
1/9 Cellectis: Monthly Information on Share Capital and Company Voting Rights 5.7%
8/17 Cellectis SA (NASDAQ: CLLS) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 5.0%
10/31 Cellectis to Hold Third Quarter and First Nine Months 2019 Earnings Call on Thursday, November 7, 2019 at 8:00 AM EST 4.0%
11/8 Cellectis: Monthly information on share capital and company voting rights 3.8%
2/12 Cellectis SA (NASDAQ: CLLS) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.5%
TOP News Decliners
3/6
Cellectis: Monthly Information on Share Capital and Company Voting Rights
-17.3%
2/21 Cellectis SA (NASDAQ: CLLS) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $22.00 price target on the stock. -9.5%
4/29 Cellectis to Hold First Quarter 2020 Earnings Call on Thursday, May 7, 2020 at 7:30 AM EDT -8.3%
4/15 Cellectis SA (NASDAQ: CLLS) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -8.0%
3/10 Form 6-K Cellectis S.A. For: Mar 10 -8.0%
10/1 Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates -7.9%
3/5 Cellectis SA (CLLS) Q4 2019 Earnings Call Transcript [The Motley Fool] -7.0%
6/5 Cellectis: Monthly Information on Share Capital and Company Voting Rights -5.9%
4/23 Cellectis SA (NASDAQ: CLLS) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -4.7%
4/2 Cellectis SA (NASDAQ: CLLS) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -4.6%
2/21 Cellectis SA (NASDAQ: CLLS) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $22.00 price target on the stock. -9.5%
4/29 Cellectis to Hold First Quarter 2020 Earnings Call on Thursday, May 7, 2020 at 7:30 AM EDT -8.3%
4/15 Cellectis SA (NASDAQ: CLLS) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -8.0%
3/10 Form 6-K Cellectis S.A. For: Mar 10 -8.0%
10/1 Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates -7.9%
3/5 Cellectis SA (CLLS) Q4 2019 Earnings Call Transcript [The Motley Fool] -7.0%
6/5 Cellectis: Monthly Information on Share Capital and Company Voting Rights -5.9%
4/23 Cellectis SA (NASDAQ: CLLS) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -4.7%
4/2 Cellectis SA (NASDAQ: CLLS) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -4.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: